EIN 27-0670085

Mmv-Medicines for Malaria Venture North America

IRS 501(c) type
501(c)(3)
Num. employees
0
Year formed
2010
Most recent tax filings
2023-12-01
Description
Mmv-Medicines for Malaria Venture North America administers and disburses funds to support projects and programs of other nonprofit organizations that aim to prevent and treat malaria in disease-endemic countries. The organization closely monitors past grants and ongoing programs while also identifying new initiatives for consideration. Its primary objective is to provide grants to nonprofit, charitable organizations with a mission to prevent and treat malaria in affected countries.
Total revenues
$2,222
2023
Total expenses
$190
2023
Total assets
$103,126
2023
Num. employees
0
2020

Program areas at Mmv-Medicines for Malaria Venture North America

Making grants to non-profit, charitable organizations for programs to prevent and treat malaria in disease-endemic countries.

Grants made by Mmv-Medicines for Malaria Venture North America

GranteeGrant descriptionAmount
Malaria No More FundSupport Projects To Prevent and Treat Malaria in Disease Endemic Regions$7,000

Who funds Mmv-Medicines for Malaria Venture North America

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Bill & Melinda Gates FoundationMalaria$36,000,000
Bill & Melinda Gates FoundationDevelopment of Solutions To Improve Global Health$239,775
Bill & Melinda Gates FoundationResearch and Learning Opportunities$20,000
...and 1 more grant received

Personnel at Mmv-Medicines for Malaria Venture North America

NameTitleCompensation
Sylvie Fonteilles-DrabekChair$0
Andrea LucardDirector and President$0
Gregory BonnaudTreasurer$0
Allison NeapoleSecretary$0
Sylvie Fonteilles DrabekChair

Financials for Mmv-Medicines for Malaria Venture North America

RevenuesFYE 12/2023
Total grants, contributions, etc.$542
Program services$0
Membership dues$0
Investment income and dividends$1,680
Net gain from sale of non-inventory assets$0
Net income from gaming activities and fundraising events, combined$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$2,222

Form 990s for Mmv-Medicines for Malaria Venture North America

Fiscal year endingDate received by IRSFormPDF link
2023-122024-04-24990EZView PDF
2022-122023-04-06990EZView PDF
2021-122022-03-16990EZView PDF
2020-122021-05-24990View PDF
2019-122021-04-12990EZView PDF
...and 8 more Form 990s
Data update history
December 31, 2023
Received grants
Identified 3 new grant, including a grant for $36,000,000 from Bill & Melinda Gates Foundation
November 25, 2023
Posted financials
Added Form 990EZ for fiscal year 2021
June 16, 2023
Posted financials
Added Form 990EZ for fiscal year 2022
May 20, 2023
Received grants
Identified 2 new grant, including a grant for $36,150,000 from Bill & Melinda Gates Foundation
September 22, 2021
Received grants
Identified 6 new grant, including a grant for $20,000,000 from Bill & Melinda Gates Foundation
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Issues
HealthDiseases and disorders
Characteristics
Conducts researchPartially liquidatedOperates internationallyTax deductible donationsNo full-time employees
General information
Address
103 Foulk Rd 202
Wilmington, DE 19803
Metro area
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
County
New Castle County, DE
Phone
(302) 485-1346
IRS details
EIN
27-0670085
Fiscal year end
December
Taxreturn type
Form 990-EZ
Year formed
2010
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H90: Medical Specialty Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
Free account sign-up

Want updates when Mmv-Medicines for Malaria Venture North America has new information, or want to find more organizations like Mmv-Medicines for Malaria Venture North America?

Create free Cause IQ account